Both in Biotechnology
Scholar Rock Holding vs Iovance Biotherapeutics
Over the past year SRRK returned +48.2% and IOVA returned +330.5%; their daily moves had a correlation of 0.25.
SRRK +48.2% IOVA +330.5%Growth of $1, one year, split-adjusted
| Metric | SRRK | IOVA |
|---|---|---|
| Price | $43.90 | $8.48 |
| Market cap | $5.35B | $3.84B |
| Today | −0.63% | −11.30% |
| 1 month | −4.9% | −40.4% |
| 6 months | −5.3% | +149.4% |
| Year to date | −0.3% | +210.6% |
| 1 year | +50.0% | +324.0% |
| Revenue growth (YoY) | — | +65.7% |
| Gross margin | — | 56.1% |
| Net margin | — | −47.6% |
| P/E (TTM) | — | — |
| Price / sales | — | 11.8× |
| Net cash | $295.9M | $297.7M |
| Dividend yield | — | — |
| Volatility (60d) | 43.2% | 128.2% |
| Short % of float | 20.3% | 15.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).